Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Looking to consolidate debt? Learn about the best ways to borrow money for debt consolidation and ease your financial burden.
16,539 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Looking for a few durable holdings to anchor a decades-long portfolio? Here are three monster stocks hold next—giants...
A longtime dividend grower is resurfacing in the spotlight after a 25% price pullback. With a higher-than-Treasury yi...
A top executive at Urban Outfitters sold a sizable block of stock in a short time frame. This article breaks down wha...
As 2026 unfolds with higher volatility, analysts flag a trio of ETFs that may help retirees balance income and risk. ...
AMH reports solid 2025 results as it navigates an overbuilt rental market, with revenue gains driven by disciplined a...
Investors who want clarity from SPX Technologies can decode the SPXC earnings transcript. This guide translates the n...
The administration unveiled a plan to create government-backed 401K-style accounts for children, aiming to give the n...
Applied Optoelectronics is poised to report Q4 FY2025 results after the close on Feb. 26, 2026. Analysts expect reven...
A federal judge found the IRS violated privacy laws by sharing confidential taxpayer information with ICE, revealing ...
Markets have celebrated a long rally, but chair nominee kevin warsh's real test may lie in credibility, independence,...
A contrarian call on badly fallen stocks can pay off when the narrative shifts. This deep dive examines could beyond ...